ARTICLE | Company News
Introgen other research news
January 2, 2001 8:00 AM UTC
INGN received a $208,000 STTR grant from the National Cancer Institute to develop its AV1Y28 vector. The vector, which contains a gene for a single chain antibody against Ras proteins, sensitizes ca...